Health Care/Hospital

Pierre Fabre Laboratories receives CHMP positive opinion for BRAFTOVI® (encorafenib) in combination with MEKTOVI® (binimetinib) for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) with a BRAFV600E mutation

* The positive CHMP opinion is based on results from the Phase II PHAROS trial,[1] which demonstrated an objective response rate (ORR) of 75% in treatment-naïve patients and 46% in previously treated patients. The safety profile is consistent with that observed in the approved metastatic melano...

2024-07-26 23:21 1428

MHX Jakarta 18-21 July 2024 Wrapped Up with Record Turnout, High Leads Generation and Strategic Partnerships

JAKARTA, Indonesia, July 26, 2024 /PRNewswire/ -- Malaysia Healthcare Travel Council (MHTC) achieved impressive results in numerous fronts inJakarta! MHTC is the pioneer in organising healthcare expo inIndonesia and the inaugural event was in Semarang in 2012. MHTC has successfully organised two ...

2024-07-26 21:02 1667

CStone Announces European Commission Approval of Sugemalimab (Cejemly®) as First-Line Treatment for Non-Small Cell Lung Cancer

* Sugemalimab becomes the world's first anti-PD-L1 monoclonal antibody (mAb) approved inEurope for first-line treatment of both squamous and non-squamous non-small cell lung cancer (NSCLC), also marking the first successful international approval of aChina domestic anti-PD-L1 mAb. * The Europ...

2024-07-26 20:16 1831

MGI and HKBU Collaborate on Advanced Sequencing Technology to Combat Doping in Sports

PARIS, July 26, 2024 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technologies that drive innovation in life science, today announced its collaboration with renowned geneticist, Professor Yannis Pitsiladis from Hong Kong Baptist University, on sports a...

2024-07-26 19:35 1050

Vantage Markets Reveals "The Future of HealthTech" in the Latest Episode of The Vantage View

PORT VILA, Vanuatu, July 26, 2024 /PRNewswire/ -- Leading multi-asset broker,  Vantage Markets

2024-07-26 17:05 853

Vantage Australia Explores HealthTech's Future in the Latest Episode of The Vantage View

SYDNEY, July 26, 2024 /PRNewswire/ -- Leading multi-asset broker, Vantage Markets

2024-07-26 17:05 1527

Innovent and WeComput Announce Strategic Partnership to Advance AI-Driven Drug Discovery and Development

SAN FRANCISCO and SUZHOU, China, July 26, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ...

2024-07-26 09:33 1523

2024 Milken Institute Asia Summit Casts Spotlight on Impactful Ideas and Purposeful Action

The 11th annual Summit adds a new focus on health and philanthropy, adding content from its flagship Future of Health Summit and Philanthropic Investors Forum to the program agenda.  SINGAPORE, July 26, 2024 /PRNewswire/ -- Global think tank Milken Institute announced today the return of its ann...

2024-07-26 09:02 1006

Angel Yeast Showcases Innovative Yeast Protein Solutions at Growth Asia 2024

SHANGHAI, July 26, 2024 /PRNewswire/ -- Angel Yeast (SH600298), a global leader in yeast manufacturing, recently introduced its yeast protein and innovative application solutions at the Growth Asia 2024 summit, which was co-hosted by leading industry media NutraIngredi...

2024-07-26 01:20 2535

ObvioHealth announces strategic investment by Guardant Health to accelerate deployment of oncology clinical trials globally

SINGAPORE, July 25, 2024 /PRNewswire/ -- ObvioHealth , a global digital clinical trials company, announces a new strategic investment by Guardant Health, Inc., a leading precision oncology company offering liquid and tissue biopsy tests across the cancer research an...

2024-07-25 16:39 1630

MoU signing between HCSA Community Services and Tzu-Chi Foundation (Singapore) to support Hepatitis C elimination initiative for former drug abusers in Singapore

SINGAPORE, July 25, 2024 /PRNewswire/ -- HCSA Community Services and Tzu-Chi Foundation (Singapore) today signed a Memorandum of Understanding (MoU) to formalise support for Phase 2 of the Educate, Test, Treat! (ETT) initiative, which has been supported by biopharmaceutical company Gilead Science...

2024-07-25 11:30 1378

Australasian College of Pharmacy and MedAdvisor Solutions Launch MedAdvisor software training for the Queensland Community Pharmacy Scope of Practice Pilot

Uplifting pharmacists' role in primary care and positioning pharmacies as  essential care destinations in local communities  CAMBERWELL, Australia, July 25, 2024 /PRNewswire/ -- MedAdvisor Solutions and the Australasian College of Pharmacy today announced the launch of the MedAdvisor software tra...

2024-07-25 05:00 1550

ADVANCION AWARDED ECOVADIS GOLD SUSTAINABILITY RATING FOR SIXTH YEAR

BUFFALO GROVE, Ill., July 24, 2024 /PRNewswire/ -- Advancion Corporation ("Advancion" or "Company"), a leading global producer of specialty ingredients for the life sciences, home and personal care, and other consumer-oriented and industrial markets, today announced it has received the EcoVadis G...

2024-07-24 23:15 1161

iHerb Welcomes Martha Stewart Wellness to its Global Assortment

IRVINE, Calif., July 24, 2024 /PRNewswire/ -- iHerb, one of the world's leading e-commerce retailers for vitamins, minerals, supplements, and other health and wellness products, today announced the addition of three innovative new supplement products fromMartha Stewart, Marquee Brands and Project...

2024-07-24 21:00 1947

SoniVie announces advancements in its renal denervation program: REDUCED-1 pilot study results, radial access First-In-Human results, and FDA pivotal IDE approval of The THRIVE global study

SoniVie announces RDN pilot results, radial access FIH and FDA pivotal IDE approval, initiating the global THRIVE study in US,Europe and Israel TEL AVIV, Israel, July 24, 2024 /PRNewswire/ -- SoniVie , which has developed a novel proprietary Therapeutic Intra-Vascular Ultras...

2024-07-24 20:09 1058

EZRA AND SIMON SINEK BRING PERSONALIZED COACHING TO 1,000 FRONTLINE HEALTHCARE WORKERS

'Gift of Coaching' program will provide free coaching to nurses, residents, paramedics, Advanced Practice Providers, and allied health professionals to help elevate their professional and personal lives NEW YORK, July 24, 2024 /PRNewswire/ -- EZRA, an LHH brand, today launched the Gift of Coachin...

2024-07-24 19:30 1114

deCODE genetics: Variants in the genome affect DNA methylation

REYKJAVIK, Iceland, July 24, 2024 /PRNewswire/ -- A new study by scientists at deCODE Genetics, subsidiary of Amgen, shows that sequence variants drive the correlation between DNA methylation and gene expression. The same variants are linked to various diseases as well as other human traits.   ...

2024-07-24 17:00 1138

For the First time in Thailand! Chulalongkorn University Researchers Found a "Glowing Land Snail"

BANGKOK, July 24, 2024 /PRNewswire/ -- Chulalongkorn University researchers have discovered Thailand's first glowing land snail  and the first one in the world in the last 80 years.  Preparations are underway to decode it...

2024-07-24 16:46 1749

Aragen Life Sciences Ltd. receives the 2024 Global Customer Value Leadership Award from Frost & Sullivan for Pioneering Excellence in Drug Discovery and Development Services

Aragen Life Sciences Ltd. excels in providing end-to-end drug discovery and development solutions, showcasing its innovative approaches and strong commitment to sustainability and customer satisfaction. SAN ANTONIO, July 24, 2024 /PRNewswire/ -- Frost & Sullivan has recognized Aragen Life Scienc...

2024-07-24 12:30 1173

SINGAPORE INKS MOU WITH QUANTINUUM, ENABLING ACCESS TO THEIR ADVANCED QUANTUM COMPUTER

SINGAPORE, July 24, 2024 /PRNewswire/ -- Singapore's National Quantum Office (NQO), Agency for Science, Technology and Research (A*STAR),National University of Singapore (NUS), National Supercomputing Centre (NSCC) and Quantinuum signed a Memorandum of Understanding (MoU) today, enabling access t...

2024-07-24 09:00 1710
12345 ... 561

Week's Top Stories